Iridex Q4 2025 revenue up 15-17% YoY to ~$14.7M; positive cash flow in quarter

IRIDEX CORP

2026-FY EPS reported -$0.26 revenue$52,675,000

Q4 2025 revenue expected $14.6-14.8M vs $12.7M prior year, +15-17% YoY.
Full-year 2025 revenue expected $52.5-52.7M vs $48.7M in 2024, +8% YoY.
Achieved positive cash flow in Q4 and expects positive adjusted EBITDA for full-year 2025.
Sold 15,800 Cyclo G6 probes in Q4 (up 19% YoY); 44 systems sold vs 47 prior year.
CEO cites cost reductions, gross margin expansion, and improved commercial efficiency as drivers.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.